Human Genome Sciences to deploy Aegis Analytical's Discoverant manufacturing intelligence solution

Mar 17 2010NewsGuard 100/100 Score

Aegis Analytical Corp., the leading provider of Enterprise Manufacturing Intelligence software, announced today that Human Genome Sciences, Inc. will deploy Aegis’ Discoverant® as its data management, analytics and reporting solution in the scale-up and production of BENLYSTA™ (belimumab), an investigational drug for the treatment of systemic lupus that has successfully completed Phase 3 trials. The submission of marketing applications for BENLYSTA is planned in the U.S., Europe and other regions in the second quarter of 2010.

Source Human Genome Sciences

Posted in: Drug Trial News | Device / Technology News | Medical Condition News

Tags: , , , , , ,

Comments (0)

Suggested Reading

AHN Biotechnologie GmbH – Premium private label manufacturing biotechnology
Cellular Origins, Fresenius Kabi sign development agreement for scalable automation of cell and gene therapy manufacturing
Study connects brain volume variations with genetic risk factors for Parkinson’s disease and ADHD
The future of UK life sciences starts in the West Midlands
SpaceX CRS-31 supports heart health, neurodegeneration, and student science
Study identifies six cancer susceptibility genes
Revolutionising organoid manufacturing: Monmouth Scientific Class 2 Biological Safety Cabinets enhance sterility and efficiency at Molecular Devices' new Life Science facility.
African production of mpox vaccines could secure the continent’s health

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
New insights on the association between genes, gut microbiota, and mental health